## Abstract ## BACKGROUND Gemcitabineβassociated thrombotic microangiopathy (TMA) is believed to be very rare, with an estimated incidence rate of 0.015%. Indications for gemcitabine are expanding, and comprehensive characterization of this complication is therefore important. ## METHODS The aut
Thrombotic microangiopathy associated withPlasmodium vivaxmalaria
β Scribed by Sunil Saharan; Utkarsh Kohli; Rakesh Lodha; Alok Sharma; Arvind Bagga
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 114 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Thrombocytopenia is a common complication of Human Immunodeficiency Virus (HIV) infection. With advanced HIV disease, the presence of both thrombocytopenia and schistocytosis are frequently observed. In such cases, the diagnosis of HIV associated TTP is often considered. This article re
## Abstract A 49βyearβold Caucasian woman presented with features suggestive of thrombotic microangiopathy (TMA). She did not respond to treatment with repeated plasma exchange and corticosteroids. A bone marrow biopsy revealed presence of metastatic carcinoma. A limited autopsy revealed presence o
Bone marrow transplant-associated thrombotic microangiopathy (BMT-TM) ranges in severity from a self-limited to a fatal disorder. There has been no specific therapy for this condition. We have previously described a clinical grading system for BMT-TM, based upon lactate dehydrogenase level (LDH) and